• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

GoodRx: The Average Price Per Insulin Unit Dropped 42%

by Jasmine Pennic 01/20/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– The average price per insulin unit dropped 42%, from $0.33 in 2019 to $0.19, in mid-2024, according to a new report from GoodRx. The drop represent the lowest average recorded in a decade. 

– Thanks to the Inflation Reduction Act and voluntary price cuts by major insulin manufacturers, prices have seen significant declines. Products like Lantus, Novolin N, Humalog, and Humulin N are now more affordable than they have been in years.

Insulin Costs Plummet: A Decade-Long High Comes to an End

The struggle to afford insulin has been a major challenge for many people with diabetes, forcing some to ration their medication or even skip doses altogether. But recent policy changes and manufacturer actions are starting to make a difference. 

Key findings from the GoodRx research reveals: 

  • Insulin prices have fallen by 42% since 2019. The average price per insulin unit dropped from $0.33 in 2019 to $0.19 in mid-2024, the lowest average recorded in a decade.
  • Generics and biosimilars are driving the price decline. The introduction of generic and biosimilar versions of popular insulins has increased competition and lowered costs.
  • Traditional insulins remain the most affordable option. Older insulins like Novolin R and Novolin N have average unit prices as low as $0.02.
  • Vials are generally cheaper than pens. While pens offer convenience, they often come with a higher price tag.

Understanding the Factors Behind the Insulin Price Drop

Several factors have contributed to the recent decline in insulin prices:

  • The Inflation Reduction Act: This legislation capped insulin costs at $35 per month for Medicare beneficiaries.
  • Manufacturer price cuts: Eli Lilly and Sanofi voluntarily cut the list prices of some of their most popular insulins and capped out-of-pocket costs for commercially insured patients.
  • Generics and biosimilars: The availability of these lower-cost alternatives has increased competition and driven down prices.
  • Retail partnerships: Manufacturers have partnered with retailers like CVS and Walmart to offer discounted insulin products.

How to Save on Insulin Costs

Even with these positive trends, affording insulin can still be a challenge for many people. The report outlines best practices to help you save:

  • Use a manufacturer savings card or patient assistance program. Many insulin manufacturers offer programs that can significantly reduce or eliminate out-of-pocket costs.
  • Shop around and compare prices. GoodRx offers discounts on insulin and allows you to compare prices at different pharmacies.
  • Consider traditional insulins and vials. If cost is a major concern, talk to your doctor about switching to a more affordable traditional insulin or using vials instead of pens.
  • Appeal your insurance coverage. If your insurance plan doesn’t cover your preferred insulin, you can appeal the decision.
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Diabetes Management, type 1 diabetes

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |